Cargando…

2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations

BACKGROUND: Serogroup B is the leading cause of invasive meningococcal disease (IMD) in United States. Among 16–23 year olds, particularly for college students, serogroup B (MenB) disease is greater than serogroups C, W, and Y combined. ACIP recommends routine immunization with MenACWY vaccine (Cate...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Liping, Goren, Amir, Lee, Lulu, Dempsey, Amanda, Srivastava, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255129/
http://dx.doi.org/10.1093/ofid/ofy210.2111
_version_ 1783373886176362496
author Huang, Liping
Goren, Amir
Lee, Lulu
Dempsey, Amanda
Srivastava, Amit
author_facet Huang, Liping
Goren, Amir
Lee, Lulu
Dempsey, Amanda
Srivastava, Amit
author_sort Huang, Liping
collection PubMed
description BACKGROUND: Serogroup B is the leading cause of invasive meningococcal disease (IMD) in United States. Among 16–23 year olds, particularly for college students, serogroup B (MenB) disease is greater than serogroups C, W, and Y combined. ACIP recommends routine immunization with MenACWY vaccine (Category A) but a non-routine recommendation based on individual clinical decision-making for MenB vaccine (Category B). Contrasting ACIP recommendations may affect how healthcare providers (HCP) prescribe meningococcal vaccines. We aimed to understand HCPs’ decision process and vaccination practice pattern to prescribe meningococcal vaccines in relation to their experience and interpretations of ACIP recommendations. METHODS: A web-based survey was conducted during August–October 2017 among a nationally representative HCP sample. Univariate analyses were conducted. RESULTS: Of 529 HCP participants, 436 (82.4%) self-identified as prescribers of MenB only or both meningococcal vaccines, and 93 (17.6%) as prescribers of MenACWY vaccine only (Table 1). When HCPs were asked to rank the most impactful factor in their decision process, 45% ranked guideline considerations as the highest in their decisions to prescribe MenACWY to 16 year olds, followed by disease related factors (36%). For MenB vaccine, 40% ranked disease related factors as the highest, followed by guideline considerations (37%); however, contrasting to MenACWY vaccine (45% vs. 24%), there was no difference (37% vs. 38%) regarding how guideline considerations drove the decision to prescribe or not to prescribe MenBvaccine (Table 2). Overall, HCPs interpreted ACIP’s MenACWY recommendation more uniformly than the MenB recommendation (Figure 1) with majority interpreting MenACWY vaccine as for everyone, whereas MenB was split into for everyone or for a sub-group based on risk factors; ~1/4th of MenACWY only prescribers did not know how to interpret the MenB recommendation. CONCLUSION: The ACIP MenB vaccine recommendation is inconsistently interpreted across HCPs and might affect their decision process and vaccination practice pattern to prescribe meningococcal vaccines resulting in disparities in access to MenBvaccines. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: L. Huang, Pfizer: Employee and Shareholder, Salary and Stocks. A. Goren, Pfizer: Collaborator, Research support. L. Lee, Pfizer: Collaborator, Research support. A. Dempsey, Pfizer, Merck: Scientific Advisor, Consulting fee. A. Srivastava, Pfizer: Employee and Shareholder, Salary.
format Online
Article
Text
id pubmed-6255129
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62551292018-11-28 2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations Huang, Liping Goren, Amir Lee, Lulu Dempsey, Amanda Srivastava, Amit Open Forum Infect Dis Abstracts BACKGROUND: Serogroup B is the leading cause of invasive meningococcal disease (IMD) in United States. Among 16–23 year olds, particularly for college students, serogroup B (MenB) disease is greater than serogroups C, W, and Y combined. ACIP recommends routine immunization with MenACWY vaccine (Category A) but a non-routine recommendation based on individual clinical decision-making for MenB vaccine (Category B). Contrasting ACIP recommendations may affect how healthcare providers (HCP) prescribe meningococcal vaccines. We aimed to understand HCPs’ decision process and vaccination practice pattern to prescribe meningococcal vaccines in relation to their experience and interpretations of ACIP recommendations. METHODS: A web-based survey was conducted during August–October 2017 among a nationally representative HCP sample. Univariate analyses were conducted. RESULTS: Of 529 HCP participants, 436 (82.4%) self-identified as prescribers of MenB only or both meningococcal vaccines, and 93 (17.6%) as prescribers of MenACWY vaccine only (Table 1). When HCPs were asked to rank the most impactful factor in their decision process, 45% ranked guideline considerations as the highest in their decisions to prescribe MenACWY to 16 year olds, followed by disease related factors (36%). For MenB vaccine, 40% ranked disease related factors as the highest, followed by guideline considerations (37%); however, contrasting to MenACWY vaccine (45% vs. 24%), there was no difference (37% vs. 38%) regarding how guideline considerations drove the decision to prescribe or not to prescribe MenBvaccine (Table 2). Overall, HCPs interpreted ACIP’s MenACWY recommendation more uniformly than the MenB recommendation (Figure 1) with majority interpreting MenACWY vaccine as for everyone, whereas MenB was split into for everyone or for a sub-group based on risk factors; ~1/4th of MenACWY only prescribers did not know how to interpret the MenB recommendation. CONCLUSION: The ACIP MenB vaccine recommendation is inconsistently interpreted across HCPs and might affect their decision process and vaccination practice pattern to prescribe meningococcal vaccines resulting in disparities in access to MenBvaccines. [Image: see text] [Image: see text] [Image: see text] DISCLOSURES: L. Huang, Pfizer: Employee and Shareholder, Salary and Stocks. A. Goren, Pfizer: Collaborator, Research support. L. Lee, Pfizer: Collaborator, Research support. A. Dempsey, Pfizer, Merck: Scientific Advisor, Consulting fee. A. Srivastava, Pfizer: Employee and Shareholder, Salary. Oxford University Press 2018-11-26 /pmc/articles/PMC6255129/ http://dx.doi.org/10.1093/ofid/ofy210.2111 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Huang, Liping
Goren, Amir
Lee, Lulu
Dempsey, Amanda
Srivastava, Amit
2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations
title 2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations
title_full 2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations
title_fullStr 2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations
title_full_unstemmed 2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations
title_short 2458. Disparities in Healthcare Providers’ Interpretation and Implementation of ACIP’s Meningococcal Vaccine Recommendations
title_sort 2458. disparities in healthcare providers’ interpretation and implementation of acip’s meningococcal vaccine recommendations
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6255129/
http://dx.doi.org/10.1093/ofid/ofy210.2111
work_keys_str_mv AT huangliping 2458disparitiesinhealthcareprovidersinterpretationandimplementationofacipsmeningococcalvaccinerecommendations
AT gorenamir 2458disparitiesinhealthcareprovidersinterpretationandimplementationofacipsmeningococcalvaccinerecommendations
AT leelulu 2458disparitiesinhealthcareprovidersinterpretationandimplementationofacipsmeningococcalvaccinerecommendations
AT dempseyamanda 2458disparitiesinhealthcareprovidersinterpretationandimplementationofacipsmeningococcalvaccinerecommendations
AT srivastavaamit 2458disparitiesinhealthcareprovidersinterpretationandimplementationofacipsmeningococcalvaccinerecommendations